The scale of repeat prescribing

  • by

The NHS spends vast amounts of pounds yearly on recurring prescriptions in primary care, but information on the degree of theirs and use is of date. Comprehending the scale of recurring prescribing and for who it’s prescribed is crucial for the NHS to prepare services and create policies to enhance patient care.
Method

Anonymous information on prescription numbers and also practice population demographics was from GP computer systems in a big urban area.

Searches have been conducted in November 2011 to determine the amounts of recurring items listed on individuals’ recurring prospect lists by age and sex.

The proportion of all prescribed items given as repeats was displaying doing searches on products issued as repeat as well as intense prescriptions.
Results

In the entire year of study 4,453,225 items have been issued of which 3,444,769 (seventy seven %) have been repeats (mean thirteen items a patient/annum) and 1,008,456 (twenty three %) severe prescriptions (mean 3.9 products every affected person per annum). The mean number of repeat Items a in-patient was 1.87 (range 0.45 ages 0 9 years; 7.1 ages 80 89 years). No less than 1 repeat medicine was recommended to forty three % of the public (range twenty % for ages 0 9; more than seventy five % for ages 60+).
Conclusion

A major proportion of the public receive the proportion and repeat prescriptions increases with age. While the proportion of repeat things to intense items has remained unchanged during the last 2 years the amount of recurring prescriptions products issued has doubled (from 5.8 to 13.3 items/patient/annum). This has implications for common practice workload, risk, NHS costs and patient convenience.

Discussion

The study of ours is a comparatively little one in contrast to Dajda and Harris (who had the ability to sample data from the entire of England). Nonetheless we feel the sample of ours, although just from one geographical region, is sufficiently large to permit guarded comparison, particularly as there aren’t any other now available data. This particular study shows the scope of change in both the entire volume of repeat prescribing items as well as the age sex distribution of the use of theirs since Harris as well as Dajda’s report of information from 17 18 years before (four). The proportion of individuals on repeat medicines is less than that reported by Dajda and Harris being forty three % as compared to forty eight %. The proportion of young adults and kids on repeats in the study of ours was twenty five % as compared to thirty five % with Harris as well as Dajda’s review The proportion of older adults on repeats will be the exact same which range from around seventy five % in the 60+ team to more than ninety % in the more than 70s. Good comparison between the study of ours which of Dajda and Harris isn’t warranted as our study utilized a local sample when compared with a national sample.